Relafen 750, chemically identified as naproxol, presents a fascinating case study from a biochemical therapeutic viewpoint. Its process of alleviating inflammation involves the selective inhibition of cyclooxygenase-2 (COX-2), an enzyme vital for the synthesis of prostanoids, potent mediators of inflammation and pain. Unlike older NSAIDs, Relafe… Read More